Journal articles on the topic 'Platinum compounds Therapeutic use'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Platinum compounds Therapeutic use.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Xiao, Xiao, James Trevor Oswald, Ting Wang, Weina Zhang, and Wenliang Li. "Use of Anticancer Platinum Compounds in Combination Therapies and Challenges in Drug Delivery." Current Medicinal Chemistry 27, no. 18 (June 3, 2020): 3055–78. http://dx.doi.org/10.2174/0929867325666181105115849.
Hassan Marouf, Bushra, and Mayyadah Mahmood Ali. "Prevention and Management of Platinum Compounds-Induced Neurotoxicity." Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ) 1 (November 22, 2021): 102–9. http://dx.doi.org/10.54133/ajms.v1i.43.
Makovec, Tomaz. "Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy." Radiology and Oncology 53, no. 2 (March 28, 2019): 148–58. http://dx.doi.org/10.2478/raon-2019-0018.
Jurgens, Sophie, Fritz E. Kuhn, and Angela Casini. "Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives." Current Medicinal Chemistry 25, no. 4 (February 12, 2018): 437–61. http://dx.doi.org/10.2174/0929867324666170529125229.
Roszczenko, Piotr, Olga Klaudia Szewczyk, Robert Czarnomysy, Krzysztof Bielawski, and Anna Bielawska. "Biosynthesized Gold, Silver, Palladium, Platinum, Copper, and Other Transition Metal Nanoparticles." Pharmaceutics 14, no. 11 (October 25, 2022): 2286. http://dx.doi.org/10.3390/pharmaceutics14112286.
Wimberger, Pauline, Barbara Klink, Konrad Gruetzmann, Julian Puppe, Daniel Klotz, Evelin Schroeck, Jan Dominik Kuhlmann, and Sarah Schott. "The activity of the conjugated antimetabolite 5-FdU-ECyd against platinum-resistant ovarian cancer." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e17077-e17077. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e17077.
Maiorano, Brigida Anna, Ugo De Giorgi, Davide Ciardiello, Giovanni Schinzari, Antonio Cisternino, Giampaolo Tortora, and Evaristo Maiello. "Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day." Biomedicines 10, no. 2 (February 9, 2022): 411. http://dx.doi.org/10.3390/biomedicines10020411.
Marcu, Loredana G. "Gender and Sex-Related Differences in Normal Tissue Effects Induced by Platinum Compounds." Pharmaceuticals 15, no. 2 (February 20, 2022): 255. http://dx.doi.org/10.3390/ph15020255.
Faraoni, Isabella, and Grazia Graziani. "Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors." Cancers 10, no. 12 (December 4, 2018): 487. http://dx.doi.org/10.3390/cancers10120487.
Krasnopolsky, Yu, D. Pylypenko, and G. Grigoryeva. "NANOMEDICINE IN ANTICANCER THERAPY." Bulletin of the National Technical University "KhPI". Series: Chemistry, Chemical Technology and Ecology 1, no. 7 (December 30, 2022): 3–13. http://dx.doi.org/10.20998/2079-0821.2022.01.
Varela-Castillo, O., P. Cordero, G. Gutiérrez-Iglesias, I. Palma, I. Rubio-Gayosso, E. Meaney, I. Ramirez-Sanchez, F. Villarreal, G. Ceballos, and N. Najera. "CHARACTERIZATION OF THE CYTOTOXIC EFFECTS OF THE COMBINATION OF CISPLATIN AND FLAVANOL (-)-EPICATECHIN ON HUMAN LUNG CANCER CELL LINE A549. AN ISOBOLOGRAPHIC APPROACH." Experimental Oncology 40, no. 1 (March 22, 2018): 19–23. http://dx.doi.org/10.31768/2312-8852.2018.40(1):19-23.
P., Pramila, Anju Abraham, Sunita Pawar, Vibha Bafna, and Monika S. Bansal. "TO STUDY THE THERAPEUTIC MANAGEMENT, DRUG RELATED PROBLEMS AND CONCOMITANT USE OF DRUGSIN PATIENTS WITH CANCER." International Journal of Pharmacy and Pharmaceutical Sciences 9, no. 6 (June 1, 2017): 139. http://dx.doi.org/10.22159/ijpps.2017v9i6.18207.
González-García, J., B. Alonso-Alvarez, GJ Nazco-Casariego, N. Batista-López, and F. Guttiérrez-Nicolás. "Plasma levels of trastuzumab in gastric cancer: Case report." Journal of Oncology Pharmacy Practice 23, no. 8 (September 23, 2016): 635–37. http://dx.doi.org/10.1177/1078155216670228.
Dasari, Shaloam, Sylvianne Njiki, Ariane Mbemi, Clement G. Yedjou, and Paul B. Tchounwou. "Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy." International Journal of Molecular Sciences 23, no. 3 (January 28, 2022): 1532. http://dx.doi.org/10.3390/ijms23031532.
Lothstein, Leonard, Judith Soberman, Deanna Parke, Jatin Gandhi, Trevor Sweatman, and Tiffany Seagroves. "Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo." Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 28, no. 5 (December 10, 2020): 451–65. http://dx.doi.org/10.3727/096504020x15898794315356.
Barr, Ronald D., Dawn Chalmers, Sonja De Pauw, William Furlong, Sheila Weitzman, and David Feeny. "Health-Related Quality of Life in Survivors of Wilms’ Tumor and Advanced Neuroblastoma: A Cross-Sectional Study." Journal of Clinical Oncology 18, no. 18 (September 18, 2000): 3280–87. http://dx.doi.org/10.1200/jco.2000.18.18.3280.
Prasad, Sahdeo, Dan DuBourdieu, Ajay Srivastava, Prafulla Kumar, and Rajiv Lall. "Metal–Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin." International Journal of Molecular Sciences 22, no. 13 (June 30, 2021): 7094. http://dx.doi.org/10.3390/ijms22137094.
Bossi, P., D. Parolini, C. Bergamini, L. D. Locati, E. Orlandi, M. Franceschini, M. Palazzi, P. Olmi, P. Potepan, and L. Licitra. "TPF induction chemotherapy (CT) followed by concomitant cisplatin/radiotherapy (cCTRT) in locally advanced nasopharyngeal cancer (LANPC)." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 6046. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.6046.
Bryde, Susanne, and Anton IPM de Kroon. "Nanocapsules of platinum anticancer drugs: development towards therapeutic use." Future Medicinal Chemistry 1, no. 8 (November 2009): 1467–80. http://dx.doi.org/10.4155/fmc.09.112.
Soejima, Takashi, and Kei-ji Iwatsuki. "Innovative Use of Palladium Compounds To Selectively Detect Live Enterobacteriaceae in Milk by PCR." Applied and Environmental Microbiology 82, no. 23 (September 23, 2016): 6930–41. http://dx.doi.org/10.1128/aem.01613-16.
Woźniak, Katarzyna, and Zofia Walter. "Induction of DNA-Protein Cross-Links by Platinum Compounds." Zeitschrift für Naturforschung C 55, no. 9-10 (October 1, 2000): 731–36. http://dx.doi.org/10.1515/znc-2000-9-1010.
Rébé, Cédric, Lucie Demontoux, Thomas Pilot, and François Ghiringhelli. "Platinum Derivatives Effects on Anticancer Immune Response." Biomolecules 10, no. 1 (December 20, 2019): 13. http://dx.doi.org/10.3390/biom10010013.
Reedijk, Jan. "Increased understanding of platinum anticancer chemistry." Pure and Applied Chemistry 83, no. 9 (March 31, 2011): 1709–19. http://dx.doi.org/10.1351/pac-con-10-11-03.
Farrell, Nicholas P. "Preclinical perspectives on the use of platinum compounds in cancer chemotherapy." Seminars in Oncology 31 (December 2004): 1–9. http://dx.doi.org/10.1053/j.seminoncol.2004.11.004.
Maillard, Maud, Félicien Le Louedec, Fabienne Thomas, and Etienne Chatelut. "Diversity of dose-individualization and therapeutic drug monitoring practices of platinum compounds: a review." Expert Opinion on Drug Metabolism & Toxicology 16, no. 10 (October 2, 2020): 907–25. http://dx.doi.org/10.1080/17425255.2020.1789590.
Domínguez-Jurado, Elena, Francisco J. Cimas, José Antonio Castro-Osma, Alberto Juan, Agustín Lara-Sánchez, Antonio Rodríguez-Diéguez, Alexandr Shafir, Alberto Ocaña, and Carlos Alonso-Moreno. "Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer." Pharmaceutics 13, no. 10 (September 26, 2021): 1559. http://dx.doi.org/10.3390/pharmaceutics13101559.
Boussaad, Ibrahim, Andriana Kotini, Emily K. Dolezal, Stephen Nimer, and Eirini P. Papapetrou. "An iPSC-Based Model Of MDS For Phenotype-Driven Gene and Drug Discovery." Blood 122, no. 21 (November 15, 2013): 859. http://dx.doi.org/10.1182/blood.v122.21.859.859.
Turkson, James, Shumin Zhang, Jay Palmer, Heidi Kay, Joseph Stanko, Linda B. Mora, Said Sebti, Hua Yu, and Richard Jove. "Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity." Molecular Cancer Therapeutics 3, no. 12 (December 1, 2004): 1533–42. http://dx.doi.org/10.1158/1535-7163.1533.3.12.
Romano, Alberto, Michele Antonio Capozza, Stefano Mastrangelo, Palma Maurizi, Silvia Triarico, Rolando Rolesi, Giorgio Attinà, Anna Rita Fetoni, and Antonio Ruggiero. "Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer." Cancers 12, no. 5 (May 17, 2020): 1266. http://dx.doi.org/10.3390/cancers12051266.
Ali, Mayyadah Mahmood, and Tavga Ahmed Aziz. "Toxic Effect of Platinum Compounds: Molecular Mechanisms of Toxicity." Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ) 1 (October 30, 2021): 81–88. http://dx.doi.org/10.54133/ajms.v1i.32.
Adokoh, Christian K. "Therapeutic potential of dithiocarbamate supported gold compounds." RSC Advances 10, no. 5 (2020): 2975–88. http://dx.doi.org/10.1039/c9ra09682e.
Samochocka, K., and M. Czauderna. "Use of INAA to study the biodistribution of platinum compounds in animals." Journal of Radioanalytical and Nuclear Chemistry Letters 106, no. 3 (August 1986): 153–57. http://dx.doi.org/10.1007/bf02166785.
Kushner, Brian H., Amy Budnick, Kim Kramer, Shakeel Modak, and Nai-Kong V. Cheung. "Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma." Cancer 107, no. 2 (2006): 417–22. http://dx.doi.org/10.1002/cncr.22004.
Herman, Terence S., Beverly A. Teicher, Lynn Van Ummersen, and Laura S. Collins. "Synthesis and testing of new platinum-based compounds for use with hyperthermia." International Journal of Radiation Oncology*Biology*Physics 13 (October 1987): 165–66. http://dx.doi.org/10.1016/0360-3016(87)91161-8.
Charignon, Elsa, Mathilde Bouché, Caroline Clave-Darcissac, Georges Dahm, Gabriel Ichim, Anthony Clotagatide, Hichem C. Mertani, et al. "In Cellulo Evaluation of the Therapeutic Potential of NHC Platinum Compounds in Metastatic Cutaneous Melanoma." International Journal of Molecular Sciences 21, no. 21 (October 22, 2020): 7826. http://dx.doi.org/10.3390/ijms21217826.
Schweer, David, J. Robert McCorkle, Jurgen Rohr, Oleg V. Tsodikov, Frederick Ueland, and Jill Kolesar. "Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer." Biomedicines 9, no. 1 (January 12, 2021): 70. http://dx.doi.org/10.3390/biomedicines9010070.
Lam, Chui, and Kai Chow. "Use of New Therapeutic Compounds in Pregnancy with Renal Disease." Current Women's Health Reviews 1, no. 3 (November 1, 2005): 197–200. http://dx.doi.org/10.2174/157340405774575196.
Stojic, Isidora, Vladimir Zivkovic, Ivan Srejovic, Nevena Jeremic, Vladimir Jakovljevic, Dragan Djuric, and Slobodan Novokmet. "The Effects of Cisplatin and Its PT(II) Analogue on Oxidative Stress of Isolated Rat Heart/ Efekti Cisplatine I PT(II) Analoga Cisplatine Na Oksidacioni Stres Izolovanog Srca Pacova." Serbian Journal of Experimental and Clinical Research 17, no. 1 (March 1, 2016): 15–20. http://dx.doi.org/10.1515/sjecr-2015-0050.
Buyana, Buhle, Tobeka Naki, Sibusiso Alven, and Blessing Atim Aderibigbe. "Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy." International Journal of Molecular Sciences 23, no. 19 (September 24, 2022): 11261. http://dx.doi.org/10.3390/ijms231911261.
Dag, Aydan, Manuela Callari, Hongxu Lu, and Martina H. Stenzel. "Modulating the cellular uptake of platinum drugs with glycopolymers." Polymer Chemistry 7, no. 5 (2016): 1031–36. http://dx.doi.org/10.1039/c5py01579k.
Bernocchi, G., M. G. Bottone, V. M. Piccolini, V. Dal Bo, G. Santin, S. A. De Pascali, D. Migoni, and F. P. Fanizzi. "Developing Central Nervous System and Vulnerability to Platinum Compounds." Chemotherapy Research and Practice 2011 (February 15, 2011): 1–14. http://dx.doi.org/10.1155/2011/315418.
Villalba, Jose M., Cristina Parrado, Monica Santos-Gonzalez, and Francisco J. Alcain. "Therapeutic use of coenzyme Q10and coenzyme Q10-related compounds and formulations." Expert Opinion on Investigational Drugs 19, no. 4 (March 31, 2010): 535–54. http://dx.doi.org/10.1517/13543781003727495.
Khokhlova, S. V., M. V. Cherkasova, N. F. Orel, S. V. Limareva, I. Ya Bazaeva, and V. A. Gorbunova. "WHICH PATIENTS WITH OVARIAN CANCER SHOWS THE COMBINATION OF TRABECTEDIN WITH PEGYLATED LIPOSOMAL DOXORUBICIN." Annals of the Russian academy of medical sciences 68, no. 11 (November 12, 2013): 115–21. http://dx.doi.org/10.15690/vramn.v68i11.852.
Köberle, Beate, and Sarah Schoch. "Platinum Complexes in Colorectal Cancer and Other Solid Tumors." Cancers 13, no. 9 (April 25, 2021): 2073. http://dx.doi.org/10.3390/cancers13092073.
Ronchi, Cristina L., Silviu Sbiera, Luitgard Kraus, Sebastian Wortmann, Sarah Johanssen, Patrick Adam, Holger S. Willenberg, Stefanie Hahner, Bruno Allolio, and Martin Fassnacht. "Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy." Endocrine-Related Cancer 16, no. 3 (September 2009): 907–18. http://dx.doi.org/10.1677/erc-08-0224.
Soejima, Takashi, Jun-ichi Minami, Jin-zhong Xiao, and Fumiaki Abe. "Innovative use of platinum compounds to selectively detect live microorganisms by polymerase chain reaction." Biotechnology and Bioengineering 113, no. 2 (August 19, 2015): 301–10. http://dx.doi.org/10.1002/bit.25711.
Szefler, Beata, Przemysław Czeleń, and Przemysław Krawczyk. "The Affinity of Carboplatin to B-Vitamins and Nucleobases." International Journal of Molecular Sciences 22, no. 7 (March 31, 2021): 3634. http://dx.doi.org/10.3390/ijms22073634.
Venturella, Giuseppe, Valeria Ferraro, Fortunato Cirlincione, and Maria Letizia Gargano. "Medicinal Mushrooms: Bioactive Compounds, Use, and Clinical Trials." International Journal of Molecular Sciences 22, no. 2 (January 10, 2021): 634. http://dx.doi.org/10.3390/ijms22020634.
Venturella, Giuseppe, Valeria Ferraro, Fortunato Cirlincione, and Maria Letizia Gargano. "Medicinal Mushrooms: Bioactive Compounds, Use, and Clinical Trials." International Journal of Molecular Sciences 22, no. 2 (January 10, 2021): 634. http://dx.doi.org/10.3390/ijms22020634.
Shoji, Eto, Sato, Soma, Fukagawa, Tomabechi, Takatori, et al. "A New Therapeutic Strategy for Recurrent Ovarian Cancer―Bevacizumab beyond Progressive Disease." Healthcare 7, no. 3 (September 19, 2019): 109. http://dx.doi.org/10.3390/healthcare7030109.